Multi-omics perspectives for gastrointestinal malignancy: A systematic review
Authors:
- Thai-Hau KooTKThai-Hau Koo
- Yi-Lin LeeYLYi-Lin Lee
- Xue-Bin LeongXLXue-Bin Leong
- Firdaus HayatiFHFirdaus Hayati
- Mohd Hazeman ZakariaMZMohd Hazeman Zakaria
- Andee Dzulkarnaen ZakariaAndee Dzulkarnaen Zakaria
Open Access
- 27 July 2025
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastrointestinal Surgery
- Vol. 17 (7)
Abstract
BACKGROUND Gastrointestinal (GI) malignancies, including gastric and colorectal cancers, remain one of the primary contributors to cancer-related illness and death globally. Despite the availability of conventional diagnostic tools, early detection and personalized treatment remain significant clinical challenges. Integrated multi-omics methods encompassing genomic, transcriptomic, proteomic, metabolomic, and microbiome profiles have emerged as powerful tools for advancing precision oncology, improving diagnostic accuracy, and informing therapeutic strategies. AIM To investigate the application of multi-omics approaches in the early detection, risk stratification, treatment optimization, and biomarker discovery of GI malignancies. METHODS The systematic review process was conducted in accordance with the PRISMA 2020 guidelines. Five databases, PubMed, ScienceDirect, Scopus, ProQuest, and Web of Science, were searched for studies published in English from 2015 onwards. Eligible studies involved human subjects and focused on multi-omics integration in GI cancers, including biomarker identification, tumor microenvironment analysis, tumor heterogeneity, organoid modeling, and artificial intelligence (AI)-driven analytics. Data extraction included study characteristics, omics modalities, clinical applications, and evaluation of study quality conducted with the Cochrane risk of bias 2.0 instrument. RESULTS A total of 17196 initially identified articles, 20 met the inclusion criteria. The findings highlight the superiority of multi-omics platforms over traditional biomarkers (e.g. , carcinoembryonic antigen and carbohydrate antigen 19-9 in detecting early stage GI cancers. Key applications include the identification of circulating tumor DNA, extracellular vesicles, lipidomic and proteomic signatures, and the adoption of AI algorithms to enhance diagnostic precision. Multi-omics analysis has also revealed the mechanisms of immune modulation, tumor microenvironment regulation, metastatic behavior, and drug resistance. Organoid models and microbiota profiling have contributed to personalized therapeutic strategies and immunotherapy optimization. CONCLUSION Multi-omics approaches offer significant advancements in the early diagnosis, prognostic evaluation, and personalized treatment of GI malignancies. Their integration with AI analytics, organoid biobanking, and microbiota modulation provides a pathway for precision oncology research.Keywords
This publication has 20 references indexed in Scilit:
- Diagnosis and prognosis prediction of gastric cancer by high-performance serum lipidome fingerprintsEMBO Molecular Medicine, 2024
- Plasma proteomic and polygenic profiling improve risk stratification and personalized screening for colorectal cancerNature Communications, 2024
- Multi-omics features of immunogenic cell death in gastric cancer identified by combining single-cell sequencing analysis and machine learningScientific Reports, 2024
- Machine learning-based analysis identifies and validates serum exosomal proteomic signatures for the diagnosis of colorectal cancerCell Reports Medicine, 2024
- BAP1-mediated MAFF deubiquitylation regulates tumor growth and is associated with adverse outcomes in colorectal cancerEuropean Journal of Cancer, 2024
- Genomic biology and therapeutic strategies of liver metastasis from gastric cancerCritical Reviews in Oncology/Hematology, 2024
- Proteomic landscape of epithelial ovarian cancerNature Communications, 2024
- Radiology and multi-scale data integration for precision oncologynpj Precision Oncology, 2024
- Advances in Precision Medicine Approaches for Colorectal Cancer: From Molecular Profiling to Targeted TherapiesACS Pharmacology & Translational Science, 2024
- Research progress on the multi-omics and survival status of circulating tumor cellsClinical and Experimental Medicine, 2024